{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T06:16:59Z","timestamp":1766902619722},"reference-count":29,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2004,10,20]],"date-time":"2004-10-20T00:00:00Z","timestamp":1098230400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Viral Hepatitis"],"published-print":{"date-parts":[[2004,11]]},"abstract":"<jats:p><jats:bold>Summary.\u2002<\/jats:bold> The diagnosis of acute hepatitis C virus (HCV) infection relies on documented positive\u2010seroconversion of HCV antibody (anti\u2010HCV). Because of the detection of seroconversion at an earlier stage by second or third generation anti\u2010HCV enzyme immunoassays (EIA), the diagnosis of acute hepatitis C (AHC) may be underestimated. The aim of this study was to evaluate whether rising anti\u2010HCV titre could be used to diagnose AHC or not. Eighteen patients with a clinical diagnosis of acute hepatitis C were enrolled, including eight cases with documented seroconversion to anti\u2010HCV and 10 cases with clinically suspected acute hepatitis C. Four chronic hepatitis C patients with acute exacerbation were selected as a control group. Serial sera were assayed with a third generation anti\u2010HCV (AxSYM, version 3.0; Abbott, Chicago, IL, USA) and recombinant immunoblot assays (RIBA; Chiron HCV 3.0 Strip; Immunoblot, Emeryville, CA, USA) and the titre of anti\u2010HCV expressed as signal\/cutoff (S\/CO) ratio and the RIBA patterns were correlated. Seven of eight documented AHC (one lacking the initial serum) and five of 10 clinically suspected AHC showed a rising pattern of S\/CO values. The initial S\/CO values on the first visit were less than 40 in 14 of 18 cases. The RIBA pattern shifted from negative\/indeterminate to positive in five of seven documented AHC and 4 of 10 clinically suspected AHC cases. Fifteen of 18 cases had seroconversions of at least one antibody, whilst 85.7% showed a rising S\/CO ratio. On the contrary, the S\/CO ratio and RIBA pattern remained unaltered in chronic hepatitis C with acute exacerbation. The rise in S\/CO was usually accompanied with an increase in the number of RIBA reactive bands and their intensity in acute hepatitis C patients. The rise in S\/CO ratios using a third generation anti\u2010HCV assay and the RIBA pattern might be used as a supplemental diagnostic criterion for acute HCV infection.<\/jats:p>","DOI":"10.1111\/j.1365-2893.2004.00533.x","type":"journal-article","created":{"date-parts":[[2004,10,20]],"date-time":"2004-10-20T17:23:34Z","timestamp":1098293014000},"page":"563-570","source":"Crossref","is-referenced-by-count":17,"title":["Is it possible to diagnose acute hepatitis C virus (HCV) infection by a rising anti\u2010HCV titre rather than by seroconversion?"],"prefix":"10.1111","volume":"11","author":[{"given":"S.\u2010N.","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.\u2010D.","family":"Tung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.\u2010M.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.\u2010M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.\u2010H.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.\u2010H.","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.\u2010H.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.\u2010S.","family":"Changchien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,10,20]]},"reference":[{"key":"e_1_2_15_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840150228"},{"key":"e_1_2_15_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1997.37897424409.x"},{"key":"e_1_2_15_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-0934(99)00146-9"},{"key":"e_1_2_15_5_2","first-page":"605","article-title":"Incidence of hepatitis C infection in a hepatitis C endemic township in southern Taiwan","volume":"13","author":"Lu SN","year":"1997","journal-title":"Kaohsiung J Med"},{"key":"e_1_2_15_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(199911)59:3<290::AID-JMV5>3.0.CO;2-R"},{"issue":"3","key":"e_1_2_15_7_2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0889-8553(21)00146-1","article-title":"The epidemiology of viral hepatitis in the United States","volume":"23","author":"Alter MJ","year":"1994","journal-title":"Gastroenterol Clin North Am"},{"key":"e_1_2_15_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2893.2002.00359.x"},{"key":"e_1_2_15_9_2","article-title":"Prediction of viremia for case of hepatitis C virus (HCV) infection using a third\u2010generation anti\u2010HCV enzyme immunoassay test","author":"Huang WS","year":"2004","journal-title":"Hepatogastroenterology"},{"key":"e_1_2_15_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1994.34994378281.x"},{"key":"e_1_2_15_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840210306"},{"key":"e_1_2_15_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011232"},{"key":"e_1_2_15_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.50.5.693"},{"key":"e_1_2_15_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/175.2.316"},{"key":"e_1_2_15_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0676.1992.tb00564.x"},{"issue":"6","key":"e_1_2_15_16_2","first-page":"914","article-title":"Changes in antibodies to specific hepatitis C virus antigens with interferon\u2010alpha therapy: analysis by recombinant immunoblot assay","volume":"88","author":"Yuki N","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_15_17_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50019"},{"key":"e_1_2_15_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(05)80358-7"},{"key":"e_1_2_15_19_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50237"},{"key":"e_1_2_15_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70353-7"},{"key":"e_1_2_15_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510290311"},{"key":"e_1_2_15_22_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268801006148"},{"issue":"3","key":"e_1_2_15_23_2","first-page":"311","article-title":"Quantitative antibody analysis: use for the diagnosis of hepatitis C virus chronic infection","volume":"61","author":"Payan C","year":"2003","journal-title":"Ann Biol Clin (Paris)"},{"key":"e_1_2_15_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1997.tb00398.x"},{"key":"e_1_2_15_25_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-131-3-199908030-00003"},{"key":"e_1_2_15_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.00979.x"},{"key":"e_1_2_15_27_2","first-page":"1535","article-title":"Effect of interferon\u2010alpha on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study","volume":"23","author":"International Interferon\u2010alpha Hepatocellular Carcinoma Study Group","year":"1998","journal-title":"Lancet"},{"key":"e_1_2_15_28_2","doi-asserted-by":"publisher","DOI":"10.1080\/00855910310001502"},{"issue":"1","key":"e_1_2_15_29_2","first-page":"205","article-title":"Long\u2010term evaluation of interferon therapy in hepatitis C virus\u2010associated cirrhosis: does IFN prevent development of hepatocellular carcinoma","volume":"5","author":"Tanaka K","year":"1998","journal-title":"Oncol Rep"},{"key":"e_1_2_15_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80399-7"}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2893.2004.00533.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2893.2004.00533.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T05:13:53Z","timestamp":1697001233000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2893.2004.00533.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10,20]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["10.1111\/j.1365-2893.2004.00533.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2893.2004.00533.x","archive":["Portico"],"relation":{},"ISSN":["1352-0504","1365-2893"],"issn-type":[{"value":"1352-0504","type":"print"},{"value":"1365-2893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10,20]]}}}